Eupraxia Pharmaceuticals ... (EPRX)
NASDAQ: EPRX
· Real-Time Price · USD
3.82
0.03 (0.92%)
At close: May 08, 2025, 3:59 PM
3.80
-0.52%
After-hours: May 08, 2025, 04:00 PM EDT
0.92% (1D)
| Bid | 3.5 |
| Market Cap | 136.94M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -27.61M |
| EPS (ttm) | -0.76 |
| PE Ratio (ttm) | -5.03 |
| Forward PE | -5.28 |
| Analyst | Buy |
| Ask | 4.14 |
| Volume | 4,771 |
| Avg. Volume (20D) | 18,095 |
| Open | 3.76 |
| Previous Close | 3.79 |
| Day's Range | 3.72 - 3.89 |
| 52-Week Range | 2.20 - 4.48 |
| Beta | 1.52 |
About EPRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol EPRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for EPRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+10.37%
Eupraxia Pharmaceuticals shares are trading higher...
Unlock content with
Pro Subscription
5 months ago
+10.43%
Eupraxia Pharmaceuticals shares are trading higher after the company unveiled new pharmacokinetic data from its Phase 2A eosinophilic esophagitis program.